Search Results 61-70 of 18950 for Hepatitis C
This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.
Viral hepatitis (hepatitis B and hepatitis C). Metabolic dysfunction-associated steatotic liver disease — formerly known as nonalcoholic fatty liver disease ...
People with chronic liver disease, including hepatitis B or hepatitis C; Anyone wishing to obtain protection (immunity). If you're concerned about your risk ...
Left untreated, hepatitis C can cause serious liver damage, cirrhosis and even death. On the next Mayo Clinic Radio, infectious diseases specialist Dr. Stacey ...
Screening laboratory result indicating Hepatitis C Virus (HCV) Genotype (GT) 1, 2, 4, 5 or 6 infection. Positive plasma HCV antibody and HCV RNA viral load ...
For hepatitis C virus infection: Adults—One tablet once a day, taken for 12 weeks. Each tablet contains sofosbuvir 400 milligrams (mg) and velpatasvir 100 ...
During her three-day checkup, she was told that X-rays had found a cancerous tumor on her liver. So, instead of talking about her Hepatitis C treatments, she ...
Glecaprevir and pibrentasvir combination is used to treat chronic hepatitis C virus (HCV) genotypes 1, 2, 3, 4, 5, or 6 infection in patients without cirrhosis ...
Research. Mayo Clinic doctors and researchers are studying new ways to diagnose and treat hepatitis C, with particular emphasis on optimal antiviral therapy ...
Medicines to control hepatitis. Medicines may limit further damage to liver cells caused by hepatitis B or C through specific treatment of these viruses.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.